Biohaven (NYSE:BHVN) stock gains as the FDA cancels an advisory meeting scheduled to review its marketing application for ...

Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, ...

Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...

Biohaven Ltd. (NYSE:BHVN) is one of the best small cap stocks with biggest upside potential. On August 12, Leerink lowered ...

Biohaven (BHVN) is jumping 10% after the FDA agreed to review the company’s potential treatment for a rare disease. The FDA’s Decision on BHVN’s Drug Candidate The FDA agreed to review BHVN ...

In a report released on August 15, William Pickering from Bernstein maintained a Buy rating on Biohaven Ltd., with a price target of $34.00. The company’s shares closed last Friday at $15.71. Take ...

Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. (NYSE: BHVN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Biohaven Ltd. investors ...

Investors in Biohaven Ltd (Symbol: BHVN) saw new options become available today, for the January 2025 expiration. One of the key data points that goes into the price an option buyer is willing to ...

Looking at the chart above, BHVN's low point in its 52 week range is $3.6933 per share, with $101 as the 52 week high point — that compares with a last trade of $18.45. Find out what 9 other ...

Price Action: BHVN shares are up 1.28% at $49.74 on the last check Friday. Photo via Wikimedia Commons ...

Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ' s sale to Pfizer Inc. for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of ...